Probiotics for Preterm Infants
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7-3
SponsorAnkara City Hospital Bilkent
About this trial
Probiotics will be used for preterm infants under 32 weeks of gestation and under 1500 g birthweight. Our aim was to investigate the effects of probiotics for stable preterm infants after extubation and who reached full enteral feeding. There are some hesitations among care-givers to start probiotics early due to safety issues although there are many positive effects of these products reported int the literature.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
preterm infants with a gestational age lower than 32 weeks and 1500 g of birthweight, reached to fully enteral feeds
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Probiotic mix preparation
Dietary supplementBifidobacterium containing supplement with vitamin D will start after preterm infants reaches full enteral feeding
Bifidobacteria
Dietary supplementRather than early period we will start probiotics after infant receive full enteral feedings
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Group 12 interventions
Trial outcomes
Primary outcomes
1
Antropometric measures
daily weight gain mg/kg/day
Time frame
2 monthsSecondary outcomes
1
Metabolic profile
Ca, P, ALP, Urea and biochmeical markers for nutritional status
Time frame
2 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: